Cargando…

Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pancreatic Cancer: A Prospective Pilot Study of Safety Using 10 mL versus 20 mL Alcohol

Background. The dose of alcohol used in EUS-CPN is not standardized. The objective was to compare the safety of 20 mL alcohol versus 10 mL alcohol during EUS-CPN for patients with pancreatic cancer-related pain. Methods. 20 patients were selected to receive 10 mL or 20 mL of alcohol during EUS-CPN....

Descripción completa

Detalles Bibliográficos
Autores principales:	LeBlanc, Julia K., Rawl, Susan, Juan, Michelle, Johnson, Cynthia, Kroenke, Kurt, McHenry, Lee, Sherman, Stuart, McGreevy, Kathy, Al-Haddad, Mohammad, DeWitt, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556397/ https://www.ncbi.nlm.nih.gov/pubmed/23365492 http://dx.doi.org/10.1155/2013/327036

Ejemplares similares

Is Endoscopic Ultrasound-Guided Celiac Ganglia Neurolysis Superior to Celiac Plexus Neurolysis?
por: Paik, Woo Hyun, et al.
Publicado: (2013)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

Performance of 3 mL versus 5 mL Discarded Volume for Blood Sampling from Central Venous Access Device
por: Lalthanthuami, HT, et al.
Publicado: (2021)

Effectiveness and safety of serial endoscopic ultrasound–guided celiac plexus block for chronic pancreatitis
por: Sey, Michael S. L., et al.
Publicado: (2015)

Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac Plexus Neurolysis
por: Comlek, Savas
Publicado: (2020)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
por: Vargas-Uricoechea, Hernando
Publicado: (2018)

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2020)

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles
por: Dashtipour, Khashayar, et al.
Publicado: (2020)

Celiac plexus neurolysis for the treatment of upper abdominal cancer pain
por: Teixeira, Manoel Jacobsen, et al.
Publicado: (2013)

Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis
por: Wyse, Jonathan M., et al.
Publicado: (2017)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
por: Bolli, Geremia B., et al.
Publicado: (2021)

Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
por: Filippelli, Mariaelena, et al.
Publicado: (2022)

Measurement of the kaon mass difference $m_L -m_S$ by the two regenerator method
por: Geweniger, C, et al.
Publicado: (1974)

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males
por: Hompesch, Marcus, et al.
Publicado: (2021)

Hepatic Arterial Phase on Gadoxetic Acid-Enhanced Liver MR Imaging: A Randomized Comparison of 0.5 mL/s and 1 mL/s Injection Rates
por: Kim, Sung Mo, et al.
Publicado: (2014)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

Comparative evaluation of anesthetic efficacy of 1.8 mL and 3.6 mL of articaine in irreversible pulpitis of the mandibular molar: A randomized clinical trial
por: Silva, Stella Agra, et al.
Publicado: (2019)

Computed tomography-guided percutaneous neurolysis of celiac plexus: technical description
por: Grubert, Renata Motta, et al.
Publicado: (2020)

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
por: Kovatchev, Boris, et al.
Publicado: (2020)

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

‘Walking epidural’: comparison of the analgesic efficacy of levobupivacaine 0.0625% + fentanyl 2mcg/mL versus ropivacaine 0.075% + fentanyl 2mcg/mL
por: Mingote, Álvaro, et al.
Publicado: (2023)

Can men with prostates sized 80 mL or larger be managed conservatively?
por: Lee, Alvin, et al.
Publicado: (2017)

Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL
por: Yu, Neng Chun
Publicado: (2019)

Spotted wolffish (Anarhichas minor) sperm cryopreservation in 5-mL cryovials
por: Beirão, J., et al.
Publicado: (2020)

Celiac plexus neurolysis for abdominal cancers: going beyond pancreatic cancer pain
por: Ambai, Vats T., et al.
Publicado: (2021)

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis
por: Sugiyama, Kazutoshi, et al.
Publicado: (2019)

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0 ng/mL to 13.0 ng/mL
por: Singh, Gurmukh, et al.
Publicado: (2015)

Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study
por: Cheng, Alice, et al.
Publicado: (2019)

Rapid 500 mL albumin bolus versus rapid 200 mL bolus followed by slower continuous infusion in post-cardiac surgery patients: a pilot before-and-after study
por: Yanase, Fumitaka, et al.
Publicado: (2023)

Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects
por: Woodley, Wendy D., et al.
Publicado: (2021)

Endoscopic ultrasonography-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer: An update
por: Pérez-Aguado, Guillermo, et al.
Publicado: (2021)

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
por: Home, Philip D., et al.
Publicado: (2017)

Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
por: Nakanishi, Shuhei, et al.
Publicado: (2018)

Evaluation of Patient Reported Satisfaction and Clinical Efficacy of Insulin Glargine 300 U/mL Versus 100 U/mL in Patients With Type 1 Diabetes Using Flash Glucose Monitoring System
por: Al Hayek, Ayman Abdullah, et al.
Publicado: (2022)

Analgesic Efficacy of Pfannenstiel Incision Infiltration with Ropivacaine 7.5 mg/mL for Caesarean Section
por: Nguyen, N. K., et al.
Publicado: (2010)

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial
por: Haluzík, Martin, et al.
Publicado: (2020)

THU073 Somapacitan Administered Subcutaneously At 5 mg/1.5 mL Or 10 mg/1.5 mL Strengths Yields Clinically Similar PK And IGF-I Profiles In Healthy Participants
por: Rasmussen, Michael Højby, et al.
Publicado: (2023)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

AB050. Laparoscopic transperitoneal enucleation of the prostate for benigh prostatic hyperplasia >80 mL
por: Feng, Ning-Han
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e4mh8t7qb24flfndevkea87v77